Clinical Trials Logo
  1. Home
  2. Male
  3. NCT00185198

Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)

Male Clinical Trial

Official title:
Multicenter, Double Blind, Randomized, Placebo Controlled Study of Testogel® (Testosterone 50-100mg) to Evaluate Its Efficacy and Safety in Men Presenting With Typical Symptoms of Partial Androgen Deficiency of Aging Males (PADAM) Over a Period of 6 Months With 12 Months Open Label Follow-up

Clinical Trial Summary

The purpose of this study is to investigate the effect of a testosterone replacement therapy called Testogel in men with PADAM. The effects on body composition (lean, fat and bone) and other symptoms of PADAM and safety will be studied.

Clinical Trial Description

The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.

Bayer Schering Pharma AG, Germany is the sponsor of the trial. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00185198
Study type Interventional
Source Bayer
Contact
Status Completed
Phase Phase 3
Start date September 2004
Completion date October 2007
View Details
See also
  Status Clinical Trial Phase
Completed NCT01207089 - To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Administration of AZD8329 Phase 1
Completed NCT05135143 - Role of Antioxidants in the Reduction of Oxidative Stress in Infertile Patients Phase 4
Completed NCT01220388 - Effects of L-lysine on Adrenal Secretion N/A
Completed NCT00410306 - Use of Nebido® to Assess Tolerability and Treatment Outcomes in Daily Clinical Practice N/A
Enrolling by invitation NCT03659175 - Characteristic of Intestinal Flora in Male Elderly With Small Intestinal Bacterial Overgrowth
Recruiting NCT06010953 - SS109 and NovoSeven ® PK / PD Profile, and Preliminary Efficacy and Safety of SS109 on Demand Treatment Phase 1/Phase 2
Recruiting NCT05748379 - Atraumatic Zirconia Abutment Versus Customized Composite Healing Abutment in Maxilla or Mandible. N/A
Recruiting NCT05964725 - The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus N/A
Not yet recruiting NCT05417711 - Efficacy of Transcutaneous Vagus Nerve Stimulation Paired With Tailor-Made Notched Music Therapy Versus Tailor-made Notched Music Training for Chronic Subjective Tinnitus N/A
Recruiting NCT06175650 - Towards a Sex-specific "Female Enhanced Recovery After Cardiac Surgery'' (F-ERAS) Pathway:
Recruiting NCT00572754 - Phase II Trial to Evaluate the Safety and Efficacy of the Dry Circumcision Method Phase 2
Completed NCT04443231 - Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
Completed NCT03998150 - Holmium Laser vs Bipolar Enucleation of a Large Volume BPH: a Randomised Controlled Study N/A
Completed NCT02825225 - A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes N/A
Completed NCT04470908 - The Effect of Moderate CYP3A Inducer Rifabutin on the Pharmacokinetics of Zanubrutinib in Healthy Males Phase 1
Recruiting NCT01727960 - The Effect of Education on Decreasing the Prevalence and Severity of Neck and Shoulder Pain N/A
Completed NCT01042249 - Pelvic Floor Muscle Training(PFMT) on Lower Urinary Tract Symptoms (LUTS) in Men With Stroke N/A
Completed NCT04143399 - HoLEP vs BPRP of a Large Volume BPH: a Randomised Controlled Trial N/A
Completed NCT04935151 - HoLEP vs BPRP in the Management of a Large Volume (> 80 gm) Symptomatic BPH N/A
Completed NCT03385161 - Intraprostatic Injection of Botulinum Toxin A Versus Ethanol for Treatment of Patients With Benign Prostatic Hyperplasia N/A